Envisagenics is a biotechnology company founded by Maria Luisa Pineda and Martin Akerman in 2014 and headquartered in New York City, New York using artificial intelligence and RNA sequencing to develop therapeutics to treat genetic diseases.
Envisagenics (@envisagenics) | Twitter
Envisagenics
https://twitter.com/envisagenics
Web
December 10, 2013